These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 15474108)

  • 1. Silverstein MicroWick.
    Silverstein H; Thompson J; Rosenberg SI; Brown N; Light J
    Otolaryngol Clin North Am; 2004 Oct; 37(5):1019-34. PubMed ID: 15474108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of a new device, the MicroWick, to deliver medication to the inner ear.
    Silverstein H
    Ear Nose Throat J; 1999 Aug; 78(8):595-8, 600. PubMed ID: 10485154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intratympanic steroid treatment of inner ear disease and tinnitus (preliminary report).
    Silverstein H; Choo D; Rosenberg SI; Kuhn J; Seidman M; Stein I
    Ear Nose Throat J; 1996 Aug; 75(8):468-71, 474, 476 passim. PubMed ID: 8828271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transtympanic gentamicin treatment using Silverstein MicroWick in Ménière's disease patients: long term outcome.
    Suryanarayanan R; Srinivasan VR; O'Sullivan G
    J Laryngol Otol; 2009 Jan; 123(1):45-9. PubMed ID: 18533050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transtympanic perfusion: indications and limitations.
    Light JP; Silverstein H
    Curr Opin Otolaryngol Head Neck Surg; 2004 Oct; 12(5):378-83. PubMed ID: 15377947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical steroid therapy using the Silverstein Microwick in sudden sensorineural hearing loss after failure of conventional treatment.
    Van Wijck F; Staecker H; Lefebvre PP
    Acta Otolaryngol; 2007 Oct; 127(10):1012-7. PubMed ID: 17851934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term follow-up after gentamicin application via the Silverstein MicroWick in the treatment of Ménière's disease.
    Hill SL; Digges EN; Silverstein H
    Ear Nose Throat J; 2006 Aug; 85(8):494, 496, 498. PubMed ID: 16999055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delivery of drugs to the inner ear.
    Hoffer ME; Balough BJ; Gottshall KR
    Curr Opin Otolaryngol Head Neck Surg; 2006 Oct; 14(5):329-31. PubMed ID: 16974146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dexamethasone perfusion of the labyrinth plus intravenous dexamethasone for Ménière's disease.
    Shea JJ; Ge X
    Otolaryngol Clin North Am; 1996 Apr; 29(2):353-8. PubMed ID: 8860933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intratympanic corticosteroids for Meniere's disease and vertigo.
    Barrs DM
    Otolaryngol Clin North Am; 2004 Oct; 37(5):955-72, v. PubMed ID: 15474104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intratympanic gentamicin for the treatment of Meniere's disease and other forms of peripheral vertigo.
    Carey J
    Otolaryngol Clin North Am; 2004 Oct; 37(5):1075-90. PubMed ID: 15474112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Intratympanic treatment in Meniere's disease: the effect of gentamicin and dexamethasone on vertigo control and hearing].
    Akkuzu B; Ozgirgin N; Ozlüoğlu LN
    Kulak Burun Bogaz Ihtis Derg; 2006; 16(5):193-9. PubMed ID: 17124437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term results of gentamicin inner ear perfusion in Ménière's disease.
    Suryanarayanan R; Cook JA
    J Laryngol Otol; 2004 Jul; 118(7):489-95. PubMed ID: 15318953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In reference to Randomized, double blind, placebo controlled trial on the safety and efficacy of continuous intratympanic dexamethasone delivered via a round window catheter for severe to profound sudden idiopathic sensorineural hearing loss after failure of systemic therapy (Laryngoscope 119:359-369, 2009).
    Nakashima T; Teranishi M; Yoshida T
    Laryngoscope; 2009 Dec; 119(12):2480; author reply 2481-2. PubMed ID: 19688859
    [No Abstract]   [Full Text] [Related]  

  • 15. Intratympanic therapies for sensorineural hearing loss and vertigo.
    Marzo SJ
    ORL Head Neck Nurs; 2003; 21(3):9-13. PubMed ID: 12961790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inner ear perfusion and the role of round window patency.
    Silverstein H; Rowan PT; Olds MJ; Rosenberg SI
    Am J Otol; 1997 Sep; 18(5):586-9. PubMed ID: 9303154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of intratympanic and intravenous dexamethasone treatment on sudden sensorineural hearing loss with diabetes.
    Kakehata S; Sasaki A; Oji K; Futai K; Ota S; Makinae K; Shinkawa H
    Otol Neurotol; 2006 Aug; 27(5):604-8. PubMed ID: 16788418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized, double blind, placebo controlled trial on the safety and efficacy of continuous intratympanic dexamethasone delivered via a round window catheter for severe to profound sudden idiopathic sensorineural hearing loss after failure of systemic therapy.
    Plontke SK; Löwenheim H; Mertens J; Engel C; Meisner C; Weidner A; Zimmermann R; Preyer S; Koitschev A; Zenner HP
    Laryngoscope; 2009 Feb; 119(2):359-69. PubMed ID: 19172627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dexamethasone inner ear perfusion by intratympanic injection in unilateral Ménière's disease: a two-year prospective, placebo-controlled, double-blind, randomized trial.
    Garduño-Anaya MA; Couthino De Toledo H; Hinojosa-González R; Pane-Pianese C; Ríos-Castañeda LC
    Otolaryngol Head Neck Surg; 2005 Aug; 133(2):285-94. PubMed ID: 16087029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes in the use of intra-tympanic gentamicin in the treatment of Ménière's disease.
    Flanagan S; Mukherjee P; Tonkin J
    J Laryngol Otol; 2006 Feb; 120(2):98-102. PubMed ID: 16359137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.